Viralgen and Axovia are set to form a partnership to progress the development and manufacturing of gene therapy for retinal ...

Catalent, a global contract development and manufacturing organization (CDMO), has been recognized with two awards in the ...

The funding of up to £500,000 is provided by LifeArc, a medical research charity, to support the development of Glox’s ...

Tagrisso and Imfinzi are projected to generate global sales of $8bn and $7bn, respectively, by 2030, according to GlobalData.

The FDA placed a clinical hold on two Atara assets, following an inspection at a third-party site that also led to a CRL for ...